Gastrointestinal Cancer News

Lifetime light alcohol consumption of one to three drinks per week was associated with the lowest combined risk for cancer and mortality, compared with never drinking and higher intakes of alcohol, according to research published in PLoS Medicine.

Researchers identified mutations in six genes associated with pancreatic cancer, according to study results published in JAMA.

CHICAGO — Aron Knickerbocker, MBA, CEO of Five Prime Therapeutics, spoke with HemOnc Today at ASCO Annual Meeting about advances in the company’s oncology program.

African-Americans and Latinos with diabetes had a twofold increased risk for pancreatic cancer, according to study findings published in Journal of the National Cancer Institute.

Although a risk assessment tool can identify patients with cancer who are at risk for hepatitis B virus (HBV) reactivation from anticancer therapy, most patients will still require HBV testing, according to study results.

CHICAGO — Venkateshwar “Venkat” Reddy, PhD, vice president and global head of translational science for Glenmark Pharmaceuticals, spoke with HemOnc Today at ASCO Annual Meeting about the company’s bispecific T-cell engager platform.

WASHINGTON — In this exclusive video, Joseph Murray, MD, of the Mayo Clinic in Rochester, Minn., shares some insight on research presented at Digestive Disease Week about checkpoint inhibitor-induced diarrhea.

WASHINGTON — Researchers found that obesity and weight gain from adolescence correlated with an increased risk for young-onset colorectal cancer among women, according to a presentation at Digestive Disease Week 2018.

Higher circulating vitamin D levels appeared associated with a lower risk for colorectal cancer among women, according to findings published in Journal of the National Cancer Institute.

WASHINGTON — In this exclusive video perspective from Digestive Disease Week 2018, the founder of ai4gi Solutions Inc., a commercial joint venture between Satis Operations and Imagia that aims to design artificial intelligence for improved gastrointestinal cancer screening, announced a codevelopment agreement with Olympus.